HomeACIU • NASDAQ
add
AC Immune SA
Previous close
$3.41
Day range
$3.10 - $3.40
Year range
$1.90 - $5.14
Market cap
315.45M USD
Avg Volume
1.44M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(CHF) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 20.07M | 442.67% |
Net income | -17.86M | -1.99% |
Net profit margin | — | — |
Earnings per share | -0.18 | 14.29% |
EBITDA | -19.65M | -14.68% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CHF) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 104.82M | -0.58% |
Total assets | 167.28M | -1.10% |
Total liabilities | 22.60M | 39.38% |
Total equity | 144.68M | — |
Shares outstanding | 99.23M | — |
Price to book | 2.34 | — |
Return on assets | -28.66% | — |
Return on capital | -32.14% | — |
Cash Flow
Net change in cash
(CHF) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -17.86M | -1.99% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2003
Website
Employees
147